COVID-19: First data shows BioNTech-Pfizer ′100% effective′ in young teenagers | Science| In-depth reporting on science and technology | DW | 31.03.2021
  1. Inhalt
  2. Navigation
  3. Weitere Inhalte
  4. Metanavigation
  5. Suche
  6. Choose from 30 Languages


COVID-19: First data shows BioNTech-Pfizer '100% effective' in young teenagers

Initial data (that has yet to be peer reviewed) suggests the BioNTech-Pfizer vaccine may work even better for young teens than it does for adults — due to an even stronger antibody reaction. The announcement came a day after Germany halted the use of AstraZeneca for anyone under 60.

Listen to audio 08:27